Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Gordon

Showing results (81-90 of 202) with videos related to

Pageof 21
Sort By:
Journal of Drug Education|July 14, 2022
Continuing Care App for Probationers and Parolees with Substance use DisordersSteven B Carswell, Michael S Gordon, Jan Gryczynski, et al.
Child Psychiatry and Human Development|August 4, 2016
Augmenting Cognitive Behavior Therapy for School Refusal with Fluoxetine: A Randomized Controlled TrialGlenn A Melvin, Amanda L Dudley, Michael S Gordon, et al.
Journal of Substance Abuse Treatment|September 29, 2004
Evaluation of a group-based substance abuse treatment program for adolescentsRobert J Battjes, Michael S Gordon, Kevin E O'Grady, et al.
Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care|October 16, 2016
Factors Associated With Receiving Rapid HIV Testing Among Individuals on Probation or ParoleMichael S Gordon, Steven B Carswell, Monique Wilson, et al.
Contemporary Clinical Trials|February 24, 2019
A randomized controlled trial of buprenorphine for probationers and parolees: Bridging the gap into treatmentMichael S Gordon, Frank J Vocci, Faye Taxman, et al.
Clinical Child Psychology and Psychiatry|January 15, 2019
Adverse events reported by anxious school refusing adolescents receiving cognitive behavioral therapy with and without fluoxetineGlenn A Melvin, Linda Finnin, John Taffe, et al.
Drug and Alcohol Dependence|June 26, 2014
A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entryMichael S Gordon, Timothy W Kinlock, Robert P Schwartz, et al.
Journal of Offender Rehabilitation|September 3, 2013
Gender Differences Among Prisoners With Pre-Incarceration Heroin Dependence Participating in a Randomized Clinical Trial of Buprenorphine TreatmentMichael S Gordon, Timothy W Kinlock, Kathryn A Couvillion, et al.
Clinical Lung Cancer|August 30, 2021
Safety and Clinical Activity of Atezolizumab Plus Ipilimumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Results From a Phase 1b TrialDeborah J Wong, Todd M Bauer, Michael S Gordon, et al.
Future Oncology (London, England)|May 13, 2015
A Phase I dose-escalation study of afatinib combined with nintedanib in patients with advanced solid tumorsMichael S Gordon, Gregory M Springett, Yungpo Bernard Su, et al.
Pageof 21

Showing results (81-90 of 202) with videos related to

Sort By:
Pageof 21
Journal of Drug Education|July 14, 2022
Continuing Care App for Probationers and Parolees with Substance use DisordersSteven B Carswell, Michael S Gordon, Jan Gryczynski, et al.
Child Psychiatry and Human Development|August 4, 2016
Augmenting Cognitive Behavior Therapy for School Refusal with Fluoxetine: A Randomized Controlled TrialGlenn A Melvin, Amanda L Dudley, Michael S Gordon, et al.
Journal of Substance Abuse Treatment|September 29, 2004
Evaluation of a group-based substance abuse treatment program for adolescentsRobert J Battjes, Michael S Gordon, Kevin E O'Grady, et al.
Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care|October 16, 2016
Factors Associated With Receiving Rapid HIV Testing Among Individuals on Probation or ParoleMichael S Gordon, Steven B Carswell, Monique Wilson, et al.
Contemporary Clinical Trials|February 24, 2019
A randomized controlled trial of buprenorphine for probationers and parolees: Bridging the gap into treatmentMichael S Gordon, Frank J Vocci, Faye Taxman, et al.
Clinical Child Psychology and Psychiatry|January 15, 2019
Adverse events reported by anxious school refusing adolescents receiving cognitive behavioral therapy with and without fluoxetineGlenn A Melvin, Linda Finnin, John Taffe, et al.
Drug and Alcohol Dependence|June 26, 2014
A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entryMichael S Gordon, Timothy W Kinlock, Robert P Schwartz, et al.
Journal of Offender Rehabilitation|September 3, 2013
Gender Differences Among Prisoners With Pre-Incarceration Heroin Dependence Participating in a Randomized Clinical Trial of Buprenorphine TreatmentMichael S Gordon, Timothy W Kinlock, Kathryn A Couvillion, et al.
Clinical Lung Cancer|August 30, 2021
Safety and Clinical Activity of Atezolizumab Plus Ipilimumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Results From a Phase 1b TrialDeborah J Wong, Todd M Bauer, Michael S Gordon, et al.
Future Oncology (London, England)|May 13, 2015
A Phase I dose-escalation study of afatinib combined with nintedanib in patients with advanced solid tumorsMichael S Gordon, Gregory M Springett, Yungpo Bernard Su, et al.
Pageof 21